U.S. market Closed. Opens in 10 hours 1 minute

SPRB | Spruce Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue10.09MN/AN/AN/AN/AN/A
Cost of Revenue70.00K429.00K381.00K102.00K12.00KN/A
Gross Profit10.02M-429.00K-381.00K-102.00K-12.00KN/A
Operating Expenses62.01M47.28M42.07M29.42M13.11M9.97M
Selling, General & Admin12.58M12.09M11.37M5.56M2.29M1.57M
Research & Development49.43M35.20M30.70M23.85M10.82M8.40M
Other Operating Expenses-49.43MN/A119.00K200.00K84.00K114.00K
Operating Income-51.99M-47.28M-42.07M-29.42M-13.11M-9.97M
Other Expenses / Income4.07M1.10M-226.00K-123.00K19.00K114.00K
Before Tax Income-47.92M-46.18M-42.29M-29.54M-13.09M-9.86M
Income Tax Expenses-97.89K-1.10M396.00K487.00K149.00K114.00K
Net Income-47.92M-45.08M-42.69M-30.03M-13.24M-9.86M
Interest Expenses483.00K420.00K345.00K323.00K65.00KN/A
Basic Shares Outstanding38.51M23.53M23.36M23.26M22.26M4.89M
Diluted Shares Outstanding38.51M23.53M23.36M23.26M22.26M4.89M
EBITDA-51.92M-45.76M-41.95M-29.22M-13.01M-9.86M
EBITDA Margin-514.65%0.00%0.00%0.00%0.00%0.00%
EBIT-47.53M-45.76M-41.95M-29.22M-13.02M-9.74M
EBIT Margin-471.15%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙